Utermark et al., 2012 - Google Patents
The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesisUtermark et al., 2012
View PDF- Document ID
- 17868669984872065456
- Author
- Utermark T
- Rao T
- Cheng H
- Wang Q
- Lee S
- Wang Z
- Iglehart J
- Roberts T
- Muller W
- Zhao J
- Publication year
- Publication venue
- Genes & development
External Links
Snippet
Class Ia phosphatidylinositol 3 kinase (PI3K) is required for oncogenic receptor-mediated transformation; however, the individual roles of the two commonly expressed class Ia PI3K isoforms in oncogenic receptor signaling have not been elucidated in vivo. Here, we show …
- 101710027440 PIK3CA 0 title abstract description 168
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Utermark et al. | The p110α and p110β isoforms of PI3K play divergent roles in mammary gland development and tumorigenesis | |
| Liu et al. | Lifelong accumulation of bone in mice lacking Pten in osteoblasts | |
| Attalla et al. | Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo | |
| Jia et al. | Should individual PI3 kinase isoforms be targeted in cancer? | |
| Thorpe et al. | PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α | |
| Bartok et al. | PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritis | |
| Wickenden et al. | Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts | |
| Jia et al. | Essential roles of PI (3) K–p110β in cell growth, metabolism and tumorigenesis | |
| Dillon et al. | Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression | |
| Ruan et al. | Axl is essential for VEGF‐A‐dependent activation of PI3K/Akt | |
| Reddig et al. | Transgenic mice overexpressing protein kinase Cε in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion | |
| Koyama et al. | Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M | |
| Hu et al. | IKKα controls formation of the epidermis independently of NF-κB | |
| Fluck et al. | Lessons in signaling and tumorigenesis from polyomavirus middle T antigen | |
| Lopardo et al. | Claudin-1 is a p63 target gene with a crucial role in epithelial development | |
| Cai et al. | Gab1 and SHP-2 promote Ras/MAPK regulation of epidermal growth and differentiation | |
| Ke et al. | Role of Gab2 in mammary tumorigenesis and metastasis | |
| Kharas et al. | Phosphoinositide 3-kinase signaling is essential for ABL oncogene–mediated transformation of B-lineage cells | |
| Zhang et al. | Haploinsufficiency of Klippel-Trenaunay syndrome gene Aggf1 inhibits developmental and pathological angiogenesis by inactivating PI3K and AKT and disrupts vascular integrity by activating VE-cadherin | |
| Ye et al. | Upregulated WDR26 serves as a scaffold to coordinate PI3K/AKT pathway-driven breast cancer cell growth, migration, and invasion | |
| Lofgren et al. | Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK | |
| Maeda et al. | Angiotensin receptor–binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity | |
| Rashel et al. | Protein kinase D1 has a key role in wound healing and skin carcinogenesis | |
| Ghoshal et al. | Loss of GTPase activating protein neurofibromin stimulates paracrine cell communication via macropinocytosis | |
| Ruschmann et al. | Tyrosine phosphorylation of SHIP promotes its proteasomal degradation |